Involvement of tumor necrosis factor-α, interleukin-1β, interleukin- 8, and interleukin-1 receptor antagonist in acute lung injury caused by local Shwartzman reaction

Pathology International

Volumn 47, Issue 1, 1997, Pages 16-24

  Imamura, Sumitaka ^a   Matsukawa, Akihiro ^a   Ohkawara, Susumu ^a   Kagayama, Motoko ^a   Yoshinaga, Masaru ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

acute lung injury; adult respiratory distress syndrome; interleukin 1 ; interleukin 1 receptor antagonist; interleukin 8; Shwartzman reaction; tumor necrosis factor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 8; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; NONHUMAN; PRIORITY JOURNAL; RABBIT; SHWARTZMAN PHENOMENON; TISSUE DISTRIBUTION; WATER CONTENT;

EID: 0031037628     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1997.tb04430.x     Document Type: Article

References (38)

1. Villar J, Slutsky AS. The incidence of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1989; 140: 814-816.
2. Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995; 273: 306-309.
3. Colby TV, Lombard CL, Yousem SA, Kitaichi M. Atlas of Pulmonary Surgical Pathology. WB Saunders, Philadelphia, 1991.
4. Swank DS, Moore SB. Roles of the neutrophil and other mediators in adult respiratory distress syndrome. Mayo Clin. Proc. 1989; 64: 1118-1132.
5. Chollet-Martin S, Montravers P, Gibert C et al. Relationships between polymorphonuclear neutrophils and cytokines in patients with adult respiratory distress syndrome. Ann. N.Y. Acad. Sci. 1994; 725: 354-366.
6. Tracey KJ. Tumor necrosis factor-Alpha. In: Thomson, AW, ed. The Cytokine Handbook, 2nd edn. Academic Press, London. 1994; 289-304.
7. Dinarello CA. The biology of interleukin-1. Chem. Immunol. 1992; 51: 1-32.
8. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 1994; 55: 97-179.
9. Mastukawa A, Ohkawara S, Maeda T, Takagi K, Yoshinaga M. Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits. Clin. Exp. Immunol. 1993; 93: 206-211.
10. Edamitsu S, Matsukawa A, Ohkawara S, Takagi K, Nariuchi H, Yoshinaga M. Role of TNFα, IL-1, and IL-1 Ra in the mediation of leukocyte infiltration and increased vascular permeability in rabbits with LPS-induced pleurisy. Clin. Immunol. Immunopathol. 1995; 75: 68-74.
11. Matsukawa A, Yoshimura T, Maeda T, Ohkawara S, Takagi K, Yoshinaga M. Neutrophil accumulation and activation by homologous IL-8 in rabbits: IL-8 induces destruction of cartilage and production of IL-1 and IL-1 receptor antagonist in vivo. J. Immunol. 1995; 154: 5418-5425.
12. Arend WP. Interleukin-1 receptor antagonist. Adv. Immunol. 1993; 54: 167-227.
13. Beck G, Habicht GS, Benach JL, Miller F. Interleukin 1: A common endogenous mediator of inflammation and the local Shwartzman reaction. J. Immunol. 1986; 136: 3025-3031.
14. Miyazaki E, Tsuda T, Abe Y, Sugisaki K, Shigenaga T. α-Naphthyl acetate esterase-1 (ANAE-1) secreted by epithelioid cells from induced rabbits lung granuloma. Exp. Lung Res. 1992; 18: 795-811.
15. Goldblum SE, Wu KM, Jay M. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J. Appl. Physiol. 1985; 59: 1978-1985.
16. Flick DA, Gifford GE. Comparison of in vitro cell cytotoxic assays for tumor necrosis factor. J. Immunol. Methods 1984; 68: 167-175.
17. Haranaka K, Satomi N, Sakurai A, Nariuchi H. Purification and partial amino acid sequence of rabbit tumor necrosis factor. Int. J. Cancer 1985; 36: 395-400.
18. Matsukawa A, Furukawa S, Ohkawara S, Takagi K, Yoshinaga M. Development of a neutralizing monoclonal antibody against IL-1 receptor antagonist and utilization for ELISA and measurement of masked IL-1 activity in biological materials. Immunol. Invest. 1994; 23: 129-142.
19. Xing Z, Kirpalani H, Torry D, Jordana M, Gauldie J. Polymorphonuclear leukocytes as a significant source of tumor necrosis factor-α in endotoxin-challenged lung tissue. Am. J. Pathol. 1993: 143: 1009-1015.
20. Turner CR, Lackey MN, Quinlan MF, Schwartz LW, Wheeldon EB. Therapeutic intervention in a rat model of adult respiratory distress syndrome. III. Cyclooxygenase pathway inhibition. Circ. Shock 1991; 34: 270-277.
21. Miyata T, Torisu M, Toh H, Goya T. Prolonged lung edema formation during the generalized Shwartzman reaction in rabbits: Can it be a model for septic lung disease? Circ. Shock 1993; 39: 44-51.
22. Thomas L, Good RA. Studies on the generalized Shwartzman reaction. I. General observations concerning the phenomenon. J. Exp. Med. 1952; 96: 605-624.
23. Parsons PE, Worthen GS, Moore EE, Tate RM, Henson PM. The association of circulating endotoxin with the development of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1989; 140: 294-301.
24. Hesse DG, Tracey KJ, Fong Y et al. Cytokine appearance in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstet. 1988; 166: 147-153.
25. Sheron N, Williams R. IL-8 as a circulating cytokine: Induction by recombinant tumor necrosis factor-alpha. Clin. Exp. Immunol. 1992; 89: 100-103.
26. Demling RH. The role of mediators in human ARDS. J. Crit. Care 1988; 3: 56-72.
27. Wedmore CV, William TJ. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 1981; 289: 646-650.
28. Sedgwick AD, Moore AR, Al-Duau A, Willoughby DA. Studies into the association between leukocyte accumulation and oedema formation. Agents Actions 1985; 17: 209-213.
29. Sekiya S, Yamashita T, Sendo F. Suppression of late phase enhanced vascular permeability in rats by selective depletion ot neutrophils with a monoclonal antibody. J. Leukocyte Biol. 1990; 48: 258-265.
30. Westlin WF, Gimbrone MA. Neutrophil-mediated damage to human vascular endothelium: Role of cytokine activation. Am. J. Pathol. 1993; 142: 117-128.
31. Casini RV, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease: A novel mechanism of chronic intestinal inflammation. J. Immunol. 1995; 154: 2434-2440.
32. Miller LC, Lynch EA, Isa S, Logan JW, Dinarello CA, Steere AC. Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 1993; 341: 146-148.
33. Malyak M, Swaney RE, Arend WP. Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies. Potential contribution from synovial fluid neutrophils. Arthritis Rheum. 1993; 36: 781-789.
34. Ferretti M, Casini-Raggi V, Pizarro TT, Eisenberg SP, Nast CC, Cominelli F. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J. Clin. Invest. 1994; 94: 449-453.
35. Fujioka N, Mukaida N, Harada A et al. Preparation of specific antibodies against murine IL-1Ra and the establishment of IL-1Ra as an endogenous regulator of bacteria-induced fulminant hepatitis in mice. J. Leukocyte Biol. 1995; 58: 90-98.
36. Chensue SW, Bienkowski M, Eessalu TE et al. Endogenous IL-1 receptor antagonist protein (IRAP) regulates schistosome egg granuloma formation and the regional lymphoid response. J. Immunol. 1993; 151: 3654-3662.
37. Goto F, Goto K, Miyata T et al. Interleukin-1 receptor antagonist in inflammatory exudate cells of rabbits: Production, purification and determination of primary structure. Immunology 1992; 77: 235-244.
38. Mori S, Goto F, Goto K et al. Cloning and sequence analysis of a cDNA for lymphocyte proliferation potentiating factor of rabbit polymorphonuclear leukocytes: Identification as rabbit interleukin 1β. Biochem. Biophys. Res. Commun. 1988; 150: 1237-1243.